204 related articles for article (PubMed ID: 11701466)
1. Niacin, but not gemfibrozil, selectively increases LP-AI, a cardioprotective subfraction of HDL, in patients with low HDL cholesterol.
Sakai T; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1783-9. PubMed ID: 11701466
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein A-I-containing lipoproteins, with or without apolipoprotein A-II, as progenitors of pre-beta high-density lipoprotein particles.
Hennessy LK; Kunitake ST; Kane JP
Biochemistry; 1993 Jun; 32(22):5759-65. PubMed ID: 8504094
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of action of gemfibrozil on lipoprotein metabolism.
Saku K; Gartside PS; Hynd BA; Kashyap ML
J Clin Invest; 1985 May; 75(5):1702-12. PubMed ID: 3923042
[TBL] [Abstract][Full Text] [Related]
4. Interaction between high-density lipoprotein subpopulations in apo B-free and abetalipoproteinemic plasma.
Cheung MC; Wolf AC; Illingworth DR
Biochim Biophys Acta; 1992 Oct; 1128(2-3):244-9. PubMed ID: 1420297
[TBL] [Abstract][Full Text] [Related]
5. Niacin and cholesterol: role in cardiovascular disease (review).
Ganji SH; Kamanna VS; Kashyap ML
J Nutr Biochem; 2003 Jun; 14(6):298-305. PubMed ID: 12873710
[TBL] [Abstract][Full Text] [Related]
6. Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.
Cheung MC; Mendez AJ; Wolf AC; Knopp RH
J Clin Invest; 1993 Feb; 91(2):522-9. PubMed ID: 8432861
[TBL] [Abstract][Full Text] [Related]
7. Gemfibrozil stimulates apolipoprotein A-I synthesis and secretion by stabilization of mRNA transcripts in human hepatoblastoma cell line (Hep G2).
Jin FY; Kamanna VS; Chuang MY; Morgan K; Kashyap ML
Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1052-62. PubMed ID: 8696946
[TBL] [Abstract][Full Text] [Related]
8. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
[TBL] [Abstract][Full Text] [Related]
9. Lp A-I and niacin: new views of an antiatherogenic duo.
Saucan L; Brinton EA
Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1707-9. PubMed ID: 11701453
[No Abstract] [Full Text] [Related]
10. Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
Cheung MC; Walden CE; Knopp RH
Metabolism; 1999 May; 48(5):658-64. PubMed ID: 10337871
[TBL] [Abstract][Full Text] [Related]
11. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
Guyton JR; Blazing MA; Hagar J; Kashyap ML; Knopp RH; McKenney JM; Nash DT; Nash SD
Arch Intern Med; 2000 Apr; 160(8):1177-84. PubMed ID: 10789612
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin selectively stimulates apolipoprotein A-I but not apolipoprotein A-II synthesis in Hep G2 cells.
Qin S; Koga T; Ganji SH; Kamanna VS; Kashyap ML
Metabolism; 2008 Jul; 57(7):973-9. PubMed ID: 18555840
[TBL] [Abstract][Full Text] [Related]
13. Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport.
Jin FY; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2020-8. PubMed ID: 9351367
[TBL] [Abstract][Full Text] [Related]
14. Conversion of apolipoprotein-specific high-density lipoprotein populations during incubation of human plasma.
Nichols AV; Blanche PJ; Shore VG; Gong EL
Biochim Biophys Acta; 1989 Feb; 1001(3):325-37. PubMed ID: 2492827
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII.
Johnson WJ; Kilsdonk EP; van Tol A; Phillips MC; Rothblat GH
J Lipid Res; 1991 Dec; 32(12):1993-2000. PubMed ID: 1816327
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of fenofibrate and extended-release niacin on high-density lipoprotein particle size distribution and cholesterol efflux capacity in dyslipidemic patients.
Franceschini G; Favari E; Calabresi L; Simonelli S; Bondioli A; Adorni MP; Zimetti F; Gomaraschi M; Coutant K; Rossomanno S; Niesor EJ; Bernini F; Benghozi R
J Clin Lipidol; 2013; 7(5):414-22. PubMed ID: 24079282
[TBL] [Abstract][Full Text] [Related]
17. HDL metabolism in HDL deficiency associated with familial hypertriglyceridemia: effect of treatment with gemfibrozil.
Kashyap ML; Saku K
Adv Exp Med Biol; 1991; 285():233-6. PubMed ID: 1907081
[TBL] [Abstract][Full Text] [Related]
18. Albumin inhibits apolipoprotein AI and AII production in human hepatoblastoma cell line (Hep G2): additive effects of oleate-albumin complex.
Sakai T; Jin FY; Kamanna VS; Kashyap ML
Atherosclerosis; 2000 Mar; 149(1):43-9. PubMed ID: 10704613
[TBL] [Abstract][Full Text] [Related]
19. Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout mice.
Holvoet P; Danloy S; Deridder E; Lox M; Bernar H; Dhoest A; Collen D
J Clin Invest; 1998 Jul; 102(2):379-85. PubMed ID: 9664079
[TBL] [Abstract][Full Text] [Related]
20. Protein transfer between A-I-containing lipoprotein subpopulations: evidence of non-transferable A-I in particles with A-II.
Cheung MC; Wolf AC; Knopp RH; Foster DM
Biochim Biophys Acta; 1992 Nov; 1165(1):68-77. PubMed ID: 1420350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
